483
Marlinz Pharma, LLCFDA 483 - Marlinz Pharma, LLC - May 04, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Marlinz Pharma, LLC, an own label distributor in Houston, revealed significant deficiencies in the firm's quality system regarding customer complaint handling. The company failed to adhere to its own standard operating procedures for documenting and processing complaints. This resulted in incomplete complaint records, specifically missing critical information such as initial contact details and the nature of the complaint.
Open in Dashboard
ID · 20798124-c205-4cf4-ab7d-976e5257db34